• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY S HBSAG REAGENT KIT; SEROLOGY TESTS USED FOR INFECTIOUS DISEASE SCREENING OF BLOOD AND PLASMA DONATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY S HBSAG REAGENT KIT; SEROLOGY TESTS USED FOR INFECTIOUS DISEASE SCREENING OF BLOOD AND PLASMA DONATIO Back to Search Results
Catalog Number 06P02-60
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/07/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event or Problem Description
An article by sara o.Dionne, hillary c.S.R.Akana, michael real, kimberly a.Elliott, brenden r.O¿neale ¿increased serologic reactivity with automated cmia testing and its implications for deceased donor eligibility determination in the united states¿, cell tissue bank (2025) 26:40 mentions repeat reactive results for samples with alinity s hiv ag/ab combo, alinity s htlv i/ii, alinity s anti-hcv, alinity s hbsag, and alinity s anti-hbc.It also states that some samples were discrepant to nat.These results could lead to rejection of donated tissue samples.No impact to donor management was reported.
 
Event or Problem Description
An article by sara o.Dionne, hillary c.S.R.Akana, michael real, kimberly a.Elliott, brenden r.O¿neale ¿increased serologic reactivity with automated cmia testing and its implications for deceased donor eligibility determination in the united states¿, cell tissue bank (2025) 26:40 mentions repeat reactive results for samples with alinity s hiv ag/ab combo, alinity s htlv i/ii, alinity s anti-hcv, alinity s hbsag, and alinity s anti-hbc.It also states that some samples were discrepant to nat.These results could lead to rejection of donated tissue samples.No impact to donor management was reported.
 
Additional Manufacturer Narrative
A complaint investigation for potential false reactive results for alinity s hbsag reagent included a review of trending data, labeling, device history record, and a complaint search.The complaint data for the product identified normal complaint activity for the complaint issue and no trends were identified.Labeling review concluded the labeling adequately addresses the issue.A device history record review did not identify any non-conformances or deviations.12,765 deceased donors were tested with alinity s hbsag i/ii, ln 6p02-60, whereof 6.35 % were repeat reactive.The reactive rate, as well as the specificity, assuming zero prevalence, is within specifications for the assay.Kit testing or review of field data was not performed, as the lot numbers in use were not available and the review of the provided data documented in the article showed performance within specifications for the assay.Based on the results of this investigation, the alinity s hbsag reagent, is performing as expected and no systemic issue or product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY S HBSAG REAGENT KIT
Common Device Name
SEROLOGY TESTS USED FOR INFECTIOUS DISEASE SCREENING OF BLOOD AND PLASMA DONATIO
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key23449354
Report Number3008344661-2025-00154
Device Sequence Number15472326
Product Code QHM
UDI-Device Identifier00380740136819
UDI-Public(01)00380740136819
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
BL125674
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Literature,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number06P02-60
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/07/2025
Supplement Date Received by Manufacturer11/10/2025
Initial Report FDA Received Date11/03/2025
Supplement Report FDA Received Date11/10/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALNTY S SYSTEM, 06P16-01, SN# UNKNOWN.; ALNTY S SYSTEM, 06P16-01, SN# UNKNOWN.
Patient SexUnknown
-
-